Humacyte, Inc.
HUMA
$1.41
$0.021.43%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -17.62M | -24.80M | -17.51M | -37.66M | 39.14M |
| Total Depreciation and Amortization | 1.79M | 1.79M | 1.87M | 1.86M | 1.83M |
| Total Amortization of Deferred Charges | 282.00K | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.25M | 5.20M | -4.14M | 10.78M | -60.01M |
| Change in Net Operating Assets | -1.31M | -8.31M | -4.12M | -1.40M | -9.56M |
| Cash from Operations | -25.10M | -26.12M | -23.90M | -26.41M | -28.60M |
| Capital Expenditure | -175.00K | -39.00K | -49.00K | -568.00K | -228.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -175.00K | -39.00K | -49.00K | -568.00K | -228.00K |
| Total Debt Issued | -- | 39.78M | -- | -- | -- |
| Total Debt Repaid | -- | -642.00K | -743.00K | -727.00K | -687.00K |
| Issuance of Common Stock | 23.32M | 56.59M | 6.20M | 3.23M | 47.43M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -38.55M | -50.05M | -340.00K | -- |
| Cash from Financing | 23.32M | 57.17M | -44.59M | 2.17M | 46.74M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.96M | 31.01M | -68.54M | -24.82M | 17.91M |